Company Filing History:
Years Active: 2025
Title: Marcin Feder - Innovator in Therapeutic Agents
Introduction
Marcin Feder is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that activate TP53, a crucial protein in cancer prevention and treatment.
Latest Patents
Marcin Feder holds a patent for 1,2,3′,5′-tetrahydro-2′H-spiro[indole-3,1′-pyrrolo[3,4-c]pyrrole]-2,3′-dione compounds. This invention relates to compounds represented by a specific formula, which can be utilized in the prevention and treatment of various diseases, including cancer, immune diseases, inflammatory conditions, allergic skin diseases, blinding diseases, and viral infections. He has 1 patent to his name.
Career Highlights
Feder is currently employed at Adamed Pharma S.A., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that can significantly impact patient care and treatment outcomes.
Collaborations
Some of his coworkers include Maria Mazur and Iwona Kalinowska, who collaborate with him in various research and development projects.
Conclusion
Marcin Feder's work in the field of therapeutic agents showcases his dedication to advancing medical science. His innovative compounds hold promise for treating serious health conditions, making him a valuable contributor to the pharmaceutical landscape.